Evaluation of left ventricular function in patients treated for malignancy in childhood;Hodnocení funkce levé komory srdeční u pacientů léčených v minulosti pro zhoubný nádor

Cor et Vasa

Volumn 50, Issue 10, 2008, Pages 378-384

  Balcárková, Pavla ^a   Elbl, Lubomír ^b   Nováková, Zuzana ^c   Hrstková, Hana ^b   Vítovec, Jiří ^a   Štastná, Jana ^b   Krontorádová, Klára ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Anthracyclines; Cardiotoxicity; Diastolic function; Echocardiography

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYTOTOXIC AGENT; DAUNORUBICIN; DOXORUBICIN; VINCA ALKALOID;

ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MITRAL VALVE; RELAXATION TIME; SYSTOLIC BLOOD PRESSURE;

EID: 57049091191     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2008.136     Document Type: Article

References (26)

1. Lipshultz SE, Colan SD, Gerber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1999;324:808-15.
2. Steinherz LJ, Steinherz PG, Tan CTC, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991;266:1672-7.
3. Lekakis J, Prassopoulos V, Anthnassidias P, Kostamis P, Moulopoulos S. Doxorubicin-induced cardiac neurotoxicity: study with iodine 123-labeled metiodobenzylguanidine. J Nucl Cardiol 1996;3:37-41.
4. Olmos RV, Bokkel Huinink WW, Greve JC, Hoefnagel CA. I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity. Clin Nucl Med 1992;17:163-7.
5. Silber JH, Jakacki RI, Larsen RL, Goldwein JW, Barber G. Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Onco 1993;21:477-9.
6. Pinkala J, Saarinen UM, Lunstrom U. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. Eur J Cancer 1996;32A:97-103.
7. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor. Blood 1986;68:1114-8.
8. Marchandise B, Schroeder E, Bosly A, et al. Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J 1989;118:92-8.
9. Stoddard MF, Seeger J, Liddell NE, Hadley TJ, Sullivan DM, Kupersmith J. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 1992;20:62-9.
10. Elbl L, Hrstková H, Tomášková I, Blažek B, Michálek J. Vliv podání dexrazoxanu (ICRF-187) na výskyt pozdní kardiotoxicity u pacientů léčných antracykliny pro hematologickou malignitu v dětství: prospektivní echokardiografick-ace sledování. Cor Vasa 2005;47: 454-61.
11. Elbl L, Hrstkova H, Tomaskova I, Michalek J. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up. Suppl Care Cancer 2006;14:128-36.
12. Otto CM. Echocardiographic evaluation of left and right ventricular systolic function. In: Otto CM. Textbook of clinical echocardiography. 2nd ed. Philadelphia: WB Saunders Comp., 2000:100-31.
13. Appleton ChP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insight from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-40.
14. Meluzín J, Novák M, Julínek J, et al. Transmitral flow velocities and times during stress transthoracic echocardiography in patients with myocardial ischemia. Eur Heart J 1993;14:1344-8.
15. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-94.
16. Nysom K, Colan SD, Lipshultz SE. Late cardiotoxicity following anthracycline therapy for childhood cancer. Prog Pediatr Cardiol 1998;8:121-8.
17. Nováková Z, Balcárková P, Honzíková N, et al. Arterial blood pressure and baroreflex sensitivity 1-18 years after completing antrhracycline therapy. Neoplasma 2007;54:162-6.
18. Hrstková H, Elbl L, Nováková Z, et al. Exercise testing in children and adolescents after completing anthracycline antitumour therapy. Scripta. Medica 2006;79:271-8.
19. Balcáxková P, Hrstková H, Elbl L, et al. Krevní tlak a funkce levé komory srdeční u pacientů léčených antracykliny. Klinická onkologie 2006;19:269-73.
20. Hrstková H, Elbl L, Nováková Z, et al. Cardiotoxicity and baroreflex sensitivity in children treated with anthracycline for leukemia. Physiol Res 2004;53:51.
21. Hirvonen HE, Salmi TT, Heinonen E, Antila KJ, Valimaki IA. Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy. Cancer 1989;64:801-5.
22. Sohn DW, Chai IH, Lee DL, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1993;30:474-80.
23. Nagueh SF, Middleton KJ, Kopelen HA, Zoghby WA, Quinones MA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
24. Kapusta L, Thijssen JM, Groot LJ, Antonius T, Mulder J, Daniels O. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. Ultrasound Med Biol 2000; 26:1099-108.
25. Kapusta L, Thijssen JM, Groot-Loonen J, van Druten JAM, Daniels O. Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for detection of subclinical cardiotolic effect of treatment with anthracyclines. Ultrasound Med Biol 2001;27:1605-14.
26. Galderisi M, Caso P, Severino S, et al. Myocardial diastolic impairment caused by left ventricular hypertrophy involves basal septum more than other walls: analysis by pulsed Doppler tissue imaging. J Hypertens 1999; 17:685-93.